80 related articles for article (PubMed ID: 7604687)
21. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
[TBL] [Abstract][Full Text] [Related]
22. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
[TBL] [Abstract][Full Text] [Related]
23. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
[TBL] [Abstract][Full Text] [Related]
24. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Witjaksono J; Lau TM; Affandi B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
[TBL] [Abstract][Full Text] [Related]
25. Management of irregular uterine bleeding and spotting associated with Norplant.
Archer DF; Philput CA; Weber ME
Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
[TBL] [Abstract][Full Text] [Related]
26. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
Sivin I
Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
[TBL] [Abstract][Full Text] [Related]
27. Acceptance, efficacy, and side effects of Norplant implants in four counties in north China.
Tu P; Qiu S; Fang H; Smith HL
Stud Fam Plann; 1997 Jun; 28(2):122-31. PubMed ID: 9216032
[TBL] [Abstract][Full Text] [Related]
28. Injectable and implantable contraceptives.
Cullins VE
Curr Opin Obstet Gynecol; 1992 Aug; 4(4):536-43. PubMed ID: 1387011
[TBL] [Abstract][Full Text] [Related]
29. Innovations in contraception: the Norplant system.
Klaisle CM; Wysocki S
NAACOGS Clin Issu Perinat Womens Health Nurs; 1992; 3(2):267-79. PubMed ID: 1596435
[TBL] [Abstract][Full Text] [Related]
30. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
31. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
32. Norplant selection and satisfaction among low-income women.
Clarke LL; Schmitt K; Bono CA; Steele J; Miller MK
Am J Public Health; 1998 Aug; 88(8):1175-81. PubMed ID: 9702143
[TBL] [Abstract][Full Text] [Related]
33. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
Runic R; Schatz F; Krey L; Demopoulos R; Thung S; Wan L; Lockwood CJ
J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417
[TBL] [Abstract][Full Text] [Related]
34. Norplant-2 subdermal contraceptive system: experience in Taiwan.
Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
[TBL] [Abstract][Full Text] [Related]
35. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
[TBL] [Abstract][Full Text] [Related]
36. Immediate postpartum insertion of the norplant contraceptive device.
Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
[TBL] [Abstract][Full Text] [Related]
37. [Norplant and its side effects].
Kato K; Joachim A; Nielsen P; Habib ND
Zentralbl Gynakol; 1995; 117(5):260-2. PubMed ID: 7793168
[TBL] [Abstract][Full Text] [Related]
38. The NORPLANT system of contraception.
Woutersz TB
Int J Fertil; 1991; 36 Suppl 3():51-6. PubMed ID: 1687404
[TBL] [Abstract][Full Text] [Related]
39. Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use.
Berenson AB; Wiemann CM; Rickerr VI; McCombs SL
Am J Obstet Gynecol; 1997 Mar; 176(3):586-92. PubMed ID: 9077611
[TBL] [Abstract][Full Text] [Related]
40. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]